Our partner is focused on developing gene-edited cell therapies for cancer. They aim to enhance the immune system’s ability to target and eliminate tumors by creating precise, engineered therapies that improve patient outcomes in oncology.

This critical hire led the Quality Assurance CMC teams for overall QA support of CMC activities, spanning from manufacturing, testing, vendor oversight, and defining overall GMP policies and procedures to successfully moving products from early to late phase clinical development and planning for commercial inspections and launch.